The Burlo Garofolo Pediatric Institute is a children's hospital located in Trieste, Italy. According to “THE”, Burlo Garofolo is the 1st institute in Italy and the 28th in the world for scientific research quality.

During the past decade, Emergency Department, IRCCS Burlo Garofolo conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Emergency Department, IRCCS Burlo Garofolo" are "Bronchiolitis" (1 trials) and "Pain" (1 trials). Many other conditions were trialed in "Emergency Department, IRCCS Burlo Garofolo" in a lesser frequency.

Most popular intervention types in "Emergency Department, IRCCS Burlo Garofolo" are "Drug" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Flushing with positive pressure" (1 trials), "Hypertonic solution (NaCl 3%)" (1 trials), "Isotonic solution (NaCl 0.9%)" (1 trials), "MicroClave ICU Medica" (1 trials) and "Normal saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Emergency Department, IRCCS Burlo Garofolo" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Emergency Department, IRCCS Burlo Garofolo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Emergency Department, IRCCS Burlo Garofolo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Emergency Department, IRCCS Burlo Garofolo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".